Not a single untruth in the post. Oh... there is one...
Arena now has FOUR worldwide partners - Teva was added to the other three.
Eisai owns ALL rights to lorcaserin for any and all indications for U.S. and the ROW as contracted last November.
The only way these indications go anywhere with a partnership is if it is New Zealand or Australia, or one of these BP buys Eisai or both Eisai and Arena.
Eisai's rights extend to ALL indications for lorcaserin.
What does that do to your educational effort here?
First, it is not down today... that makes you a liar.
Second, if it goes to ZERO the most a short can make is 4.29 per share shorted.
The is more room above than below... a lot more room.
Belviq has been consistently growing its market share and has been in a steady and well defined rising trend. Sales have not stagnated. The summer slump has showed up, as we all expected it to, but once kids are back in school the vacations will be over and the trajectory will have bottomed and start back up until the holidays are hit in November/December.
Belviq is not a drug with an immediate result. ARNA will not be a stock with an immediate result either.
Come on. It was hedgies just doin' thar thang. Know what I mean?
Paging nurse Ratched... paging nurse Ratched...
Just telling you what I said.
If you really are a technical analyst, as you claim to be, then you must be aware that consolidation patterns carry both and upside and a downside target depending upon which way the breakout goes.... right?
4.30's is the minimum downside target and the very day that 5.75 broke down I was here to tell the board that we had a minimum target in the 4.30's.
No need for me to plausibly deny anything about that.
See... no sooner than I mention idiot clones of my ID and here we are.
No, name calling is no substitute for evidence. Show me what I said and when I said it.
I can play fair. Just make sure it was not one of about 3 or 4 clones who pretend to be me from time to time.
That news actually moved it to almost 8.
However, there is no more guarantee that news alone was responsible for that move, or that a lack of news will mean we cannot move up from here.
Here you go... from earlier in the week, just in case you missed it.
Failure to get over 5 this week and...
by sp500chartdotcom • Jul 28, 2014 2:17 PM Remove
I could see 3.50-3.60. Sorry to mention it, and it seems to defy any sense of logic.
I just think retail longs are that weak.
Where did I say this could not happen? I do not remember saying that anywhere.
All I said was that 4.30's was a minimum target from the trading pattern that set up from the first of the year and broke down when it got under 5.75.
If you say you are a technical analyst and have failed to see what I am talking about then I have to wonder about your eyesight.
If 4 breaks then look for support around 3.50 on a sloping down trend support line.
What exactly are you referring to? That ARNA will never see 1.28 again? So far I am right on that...
It was not 4 months ago that shorts such as yourself were characterizing the TaiGen stock as a totally stupid idea that was nothing more than some vestigal appendage of a deal made more than a decade ago and, as such, it deserved NO ATTENTION.
Now, after most of it was sold, it has suddenly become a PROMISING asset that was sold in an act of desperation.
What part about having 190 million in the bank without the sale did you fail to pick up on?
So, you are telling me that Belviq, it's additional indications, and Arena's pipeline is worth 28 cents at this point in time.
That IS what you are saying, whether you realize it or not.
Do you really mean that? I want to get that on record.